%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Simone U. Dalm, Willemijne A. M. E. Schrijver, Anieta M. Sieuwerts, Maxime P. Look, Angelique C. J. Ziel - van der Made, Vanja de Weerd, John W. Martens, Paul J. van Diest, Marion de Jong, Carolien H. M. van Deurzen
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref002)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref003)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref004)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref006)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref010)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref011)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170536.ref012)>>
endobj
14 0 obj
[26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R]
endobj
26 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 661.9102 m
199.9998 661.9102 l
199.9998 662.4102 l
575.9997 662.4102 l
f*
0.83 0.64 0.02 0 k
285.6189 575.8866 m
290.3811 575.8866 l
h
f*
218.0409 536.8819 m
222.8031 536.8819 l
h
f*
227.2252 536.8819 m
231.9874 536.8819 l
h
f*
503.5465 523.8992 m
508.3087 523.8992 l
h
f*
512.7874 523.8992 m
517.5496 523.8992 l
h
f*
256.5921 497.8772 m
261.3543 497.8772 l
h
f*
203.4142 458.8724 m
208.1764 458.8724 l
h
f*
255.1748 380.863 m
259.937 380.863 l
h
f*
265.0961 380.863 m
274.6205 380.863 l
h
f*
455.7543 211.9181 m
465.2787 211.9181 l
h
f*
469.7575 211.9181 m
479.2252 211.9181 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Targeting)Tj
4.3981 0 Td
(the)Tj
1.5934 0 Td
(GRPR)Tj
3.0912 0 Td
(and)Tj
1.8679 0 Td
(SSTR2)Tj
3.4195 0 Td
(for)Tj
1.3785 0 Td
(nuclear)Tj
3.4553 0 Td
(imaging)Tj
3.676 0 Td
(and/or)Tj
3.0197 0 Td
(treatment)Tj
4.4101 0 Td
(has)Tj
1.8141 0 Td
(the)Tj
1.5934 0 Td
(potential)Tj
3.9506 0 Td
(to)Tj
-37.6678 -1.474 Td
(improve)Tj
3.7357 0 Td
(BC)Tj
1.5993 0 Td
(care)Tj
2.1424 0 Td
(in)Tj
0.9847 0 Td
(primary)Tj
3.5209 0 Td
(as)Tj
1.2651 0 Td
(well)Tj
1.9097 0 Td
(as)Tj
1.2651 0 Td
(metastatic)Tj
4.7384 0 Td
(disease.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 606.9543 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 589.9464 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Breast)Tj
2.6872 0 Td
(cancer)Tj
2.8459 0 Td
(\(BC\))Tj
2.143 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4684 0 Td
(second)Tj
3.016 0 Td
(most)Tj
2.2054 0 Td
(common)Tj
3.8437 0 Td
(cancer)Tj
2.846 0 Td
(found)Tj
2.6192 0 Td
(in)Tj
1.0318 0 Td
(women)Tj
3.2031 0 Td
(and)Tj
1.7348 0 Td
(the)Tj
1.4683 0 Td
(fifth)Tj
1.8879 0 Td
(cause)Tj
2.3868 0 Td
(of)Tj
-36.2322 -1.2982 Td
(cancer)Tj
2.8402 0 Td
(related)Tj
2.9481 0 Td
(death)Tj
2.4321 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5987 0 Td
(The)Tj
1.7858 0 Td
(disease)Tj
3.0161 0 Td
(is)Tj
0.8447 0 Td
(very)Tj
1.9275 0 Td
(heterogeneous.)Tj
6.2532 0 Td
(Different)Tj
3.8664 0 Td
(subtypes)Tj
3.6681 0 Td
(with)Tj
1.9955 0 Td
(distinctive)Tj
-33.1764 -1.2983 Td
(morphological)Tj
6.0604 0 Td
(and)Tj
1.7291 0 Td
(molecular)Tj
4.2179 0 Td
(characteristics)Tj
5.9074 0 Td
(exist.)Tj
2.2564 0 Td
(The)Tj
1.7858 0 Td
(four)Tj
1.9105 0 Td
(major)Tj
2.6079 0 Td
(intrinsic)Tj
3.5773 0 Td
(BC)Tj
1.4626 0 Td
(subtypes)Tj
3.6681 0 Td
(are)Tj
-35.1834 -1.3039 Td
(luminal)Tj
3.3108 0 Td
(A,)Tj
1.1282 0 Td
(luminal)Tj
3.3108 0 Td
(B,)Tj
1.0205 0 Td
(human)Tj
3.0784 0 Td
(epidermal)Tj
4.2519 0 Td
(growth)Tj
3.0728 0 Td
(factor)Tj
2.5455 0 Td
(2)Tj
0.6916 0 Td
(\(HER2,)Tj
/F11 1 Tf
3.2202 0 Td
[()]TJ
/F7 1 Tf
(\)-driven)Tj
6.2475 0 Td
(and)Tj
1.7291 0 Td
(basal-like)Tj
-33.6073 -1.2983 Td
(BC)Tj
1.4626 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(3)Tj
0 g
(].)Tj
1.2642 0 Td
(Treatment)Tj
4.4447 0 Td
(and)Tj
1.7348 0 Td
(prognosis)Tj
4.1216 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(disease)Tj
3.0217 0 Td
(are)Tj
1.4457 0 Td
(highly)Tj
2.7099 0 Td
(dependent)Tj
4.4617 0 Td
(on)Tj
1.2756 0 Td
(these)Tj
2.2507 0 Td
(subtypes;)Tj
-31.9349 -1.2982 Td
(luminal)Tj
3.3108 0 Td
(A)Tj
0.9014 0 Td
(and)Tj
1.7291 0 Td
(luminal)Tj
3.3109 0 Td
(B)Tj
0.7993 0 Td
(tumors)Tj
3.1068 0 Td
(have)Tj
2.0579 0 Td
(a)Tj
0.652 0 Td
(better)Tj
2.5455 0 Td
(prognosis)Tj
4.1272 0 Td
(than)Tj
2.0239 0 Td
(basal-like)Tj
3.9855 0 Td
(BC)Tj
1.4627 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(3)Tj
0 g
(].)Tj
1.2586 0 Td
(Although)Tj
-32.5358 -1.3039 Td
(multiple)Tj
3.5659 0 Td
(therapy)Tj
3.2485 0 Td
(options)Tj
3.2258 0 Td
(for)Tj
1.3833 0 Td
(BC)Tj
1.4627 0 Td
(exist,)Tj
2.262 0 Td
(2030%)Tj
3.3959 0 Td
(of)Tj
1.0148 0 Td
(BC)Tj
1.4626 0 Td
(patients)Tj
3.3676 0 Td
(experience)Tj
4.507 0 Td
(relapse)Tj
2.9991 0 Td
(with)Tj
1.9956 0 Td
(meta-)Tj
-33.8908 -1.2983 Td
(static)Tj
2.3017 0 Td
(disease)Tj
3.016 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
-4.1215 -1.2983 Td
(Peptide)Tj
3.2371 0 Td
(receptor)Tj
3.5603 0 Td
(mediated)Tj
3.9401 0 Td
(nuclear)Tj
3.1918 0 Td
(imaging)Tj
3.4866 0 Td
(and)Tj
1.7348 0 Td
(peptide)Tj
3.1918 0 Td
(receptor)Tj
3.5546 0 Td
(radionuclide)Tj
5.2951 0 Td
(therapy)Tj
3.2428 0 Td
(are)Tj
-35.6312 -1.3039 Td
(methods)Tj
3.685 0 Td
(successfully)Tj
4.8642 0 Td
(used)Tj
2.0579 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(clinic)Tj
2.3981 0 Td
(for)Tj
1.3833 0 Td
(imaging)Tj
3.4866 0 Td
(and)Tj
1.7291 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(neuroendocrine)Tj
6.6387 0 Td
(tumors)Tj
-33.9021 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(These)Tj
2.5682 0 Td
(methods)Tj
3.685 0 Td
(are)Tj
1.4456 0 Td
(based)Tj
2.4775 0 Td
(on)Tj
1.2756 0 Td
(targeting)Tj
3.787 0 Td
(receptors)Tj
3.9175 0 Td
(that)Tj
1.7801 0 Td
(are)Tj
1.4514 0 Td
(overexpressed)Tj
5.8506 0 Td
(on)Tj
1.2756 0 Td
(cancer)Tj
2.8403 0 Td
(cells)Tj
-33.9531 -1.2982 Td
(using)Tj
2.3867 0 Td
(radiolabeled)Tj
5.1364 0 Td
(peptide)Tj
3.1974 0 Td
(analogs.)Tj
3.4413 0 Td
(Regarding)Tj
4.3426 0 Td
(BC,)Tj
1.6894 0 Td
(multiple)Tj
3.566 0 Td
(studies)Tj
2.982 0 Td
(have)Tj
2.0636 0 Td
(demonstrated)Tj
5.76 0 Td
(overex-)Tj
-34.5654 -1.3039 Td
(pression)Tj
3.5773 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(gastrin)Tj
2.965 0 Td
(releasing)Tj
3.7587 0 Td
(peptide)Tj
3.1975 0 Td
(receptor)Tj
3.5546 0 Td
(\(GRPR\))Tj
3.4186 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(somatostatin)Tj
5.3575 0 Td
(receptor)Tj
3.5546 0 Td
(2)Tj
-35.0643 -1.2983 Td
(\(SSTR2\).)Tj
3.7813 0 Td
(In)Tj
1.0999 0 Td
(line)Tj
1.7008 0 Td
(with)Tj
1.9955 0 Td
(this,)Tj
1.8936 0 Td
(several)Tj
2.931 0 Td
(pre-clinical)Tj
4.7338 0 Td
(as)Tj
1.0091 0 Td
(well)Tj
1.8142 0 Td
(as)Tj
1.0148 0 Td
(clinical)Tj
3.0671 0 Td
(studies)Tj
2.982 0 Td
(demonstrated)Tj
5.7599 0 Td
(feasibility)Tj
-33.783 -1.2983 Td
(of)Tj
1.0147 0 Td
(imaging)Tj
3.4866 0 Td
(and/or)Tj
2.9367 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(BC)Tj
1.4626 0 Td
(with)Tj
1.9956 0 Td
(GRPR)Tj
2.7383 0 Td
(and)Tj
1.7291 0 Td
(SSTR2)Tj
2.88 0 Td
(radioligands)Tj
5.176 0 Td
(with)Tj
1.9956 0 Td
(promising)Tj
-30.5686 -1.2982 Td
(results,)Tj
3.033 0 Td
(and)Tj
1.7291 0 Td
(indicated)Tj
3.9402 0 Td
(specific)Tj
3.1917 0 Td
(BC)Tj
1.4627 0 Td
(patients)Tj
3.3676 0 Td
(groups)Tj
2.9706 0 Td
(that)Tj
1.7745 0 Td
(can)Tj
1.6271 0 Td
(benefit)Tj
2.9764 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4683 0 Td
(application)Tj
4.6828 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
-35.4441 -1.3039 Td
(radioligands)Tj
5.176 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
-3.9798 -1.2983 Td
(However,)Tj
4.0818 0 Td
(previous)Tj
3.6454 0 Td
(studies)Tj
2.9877 0 Td
(were)Tj
2.1203 0 Td
(solely)Tj
2.4604 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(primary)Tj
3.4582 0 Td
(BC)Tj
1.4627 0 Td
(while)Tj
2.3698 0 Td
(BC-related)Tj
4.5354 0 Td
(death)Tj
2.4321 0 Td
(is)Tj
-34.4974 -1.2983 Td
(largely)Tj
2.8573 0 Td
(caused)Tj
2.9196 0 Td
(by)Tj
1.1792 0 Td
(metastatic)Tj
4.2803 0 Td
(disease.)Tj
3.2428 0 Td
(Targeting)Tj
4.1046 0 Td
(the)Tj
1.4683 0 Td
(GRPR)Tj
2.7383 0 Td
(and)Tj
1.7291 0 Td
(SSTR2)Tj
2.88 0 Td
(could)Tj
2.4548 0 Td
(thus)Tj
1.9332 0 Td
(especially)Tj
4.0195 0 Td
(be)Tj
-35.807 -1.3039 Td
(advantageous)Tj
5.6352 0 Td
(for)Tj
1.3833 0 Td
(treatment)Tj
4.1385 0 Td
(of)Tj
1.0148 0 Td
(metastatic)Tj
4.2747 0 Td
(BC.)Tj
-15.2503 -1.2983 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(study,)Tj
2.6192 0 Td
(we)Tj
1.3266 0 Td
(examined)Tj
4.1272 0 Td
(the)Tj
/F11 1 Tf
1.4683 0 Td
[()14()]TJ
/F7 1 Tf
2.6249 0 Td
(and)Tj
/F11 1 Tf
1.7291 0 Td
[()20()]TJ
/F7 1 Tf
2.7779 0 Td
(mRNA)Tj
3.0785 0 Td
(expression)Tj
4.4673 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(primary)Tj
-31.589 -1.2982 Td
(tumors)Tj
3.101 0 Td
(and)Tj
1.7348 0 Td
(paired)Tj
2.761 0 Td
(metastases,)Tj
4.6601 0 Td
(in)Tj
1.0318 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.4639 0 Td
(whether)Tj
3.4753 0 Td
(nuclear)Tj
3.1918 0 Td
(imaging)Tj
3.4922 0 Td
(and)Tj
1.7291 0 Td
(therapy)Tj
-32.0879 -1.3039 Td
(might)Tj
2.5965 0 Td
(also)Tj
1.7688 0 Td
(be)Tj
1.1508 0 Td
(beneficial)Tj
4.0479 0 Td
(for)Tj
1.3833 0 Td
(metastatic)Tj
4.2803 0 Td
(BC.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 273.9968 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(Methods)Tj
/F0 1 Tf
-6.4961 -1.4976 Td
(Human)Tj
3.4063 0 Td
(BC)Tj
1.5968 0 Td
(cases)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 239.0173 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Retrospectively,)Tj
6.5366 0 Td
(we)Tj
1.3266 0 Td
(selected)Tj
3.3449 0 Td
(74)Tj
1.1735 0 Td
(formalin-fixed)Tj
6.0264 0 Td
(paraffin-embedded)Tj
7.8973 0 Td
(\(FFPE\))Tj
3.0841 0 Td
(primary)Tj
3.4525 0 Td
(BCs)Tj
1.8255 0 Td
(and)Tj
1.7292 0 Td
(77)Tj
-36.3966 -1.3039 Td
(corresponding)Tj
6.0604 0 Td
(metastases)Tj
4.4333 0 Td
(from)Tj
2.2054 0 Td
(an)Tj
1.2019 0 Td
(existing)Tj
3.3165 0 Td
(database)Tj
3.6396 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(University)Tj
4.405 0 Td
(Medical)Tj
3.4299 0 Td
(Center)Tj
2.948 0 Td
(Utrecht)Tj
-34.1232 -1.2982 Td
(and)Tj
1.7291 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(pathology)Tj
4.1782 0 Td
(archive)Tj
3.1238 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(Erasmus)Tj
3.6623 0 Td
(Medical)Tj
3.4356 0 Td
(Center)Tj
2.948 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(12)Tj
0 g
(].)Tj
1.7348 0 Td
(Fresh)Tj
2.4321 0 Td
(frozen)Tj
2.7722 0 Td
(\(FF\))Tj
1.9559 0 Td
(tis-)Tj
-35.8693 -1.2983 Td
(sue)Tj
1.5306 0 Td
(of)Tj
1.0148 0 Td
(6)Tj
0.6974 0 Td
(paired)Tj
2.7609 0 Td
(primary)Tj
3.4526 0 Td
(tumors)Tj
3.1067 0 Td
(and)Tj
1.7291 0 Td
(regional)Tj
3.481 0 Td
(lymph)Tj
2.7892 0 Td
(node)Tj
2.2281 0 Td
(metastases)Tj
4.4333 0 Td
(were)Tj
2.1203 0 Td
(also)Tj
1.7688 0 Td
(included.)Tj
3.9402 0 Td
(Each)Tj
-35.053 -1.3039 Td
(specimen)Tj
4.0024 0 Td
(was)Tj
1.7008 0 Td
(reviewed)Tj
3.7928 0 Td
(by)Tj
1.1848 0 Td
(a)Tj
0.652 0 Td
(pathologist)Tj
4.6488 0 Td
(\(CHMvD\))Tj
4.4163 0 Td
(to)Tj
1.0262 0 Td
(confirm)Tj
3.4412 0 Td
(the)Tj
1.474 0 Td
(presence)Tj
3.7077 0 Td
(of)Tj
1.0148 0 Td
(malignancy)Tj
4.8642 0 Td
(and)Tj
-35.926 -1.2983 Td
(to)Tj
1.0147 0 Td
(determine)Tj
4.3144 0 Td
(the)Tj
1.4626 0 Td
(percentage)Tj
4.5411 0 Td
(of)Tj
1.0035 0 Td
(tumor)Tj
2.7382 0 Td
(cells)Tj
1.9105 0 Td
(\(cut-off)Tj
3.2315 0 Td
(point)Tj
2.3528 0 Td
(of)Tj
/F12 1 Tf
0 Tc
1.0034 0 Td
(>)Tj
/F7 1 Tf
-0.004 Tc
(50%)Tj
2.6929 0 Td
(tumor)Tj
2.7383 0 Td
(cells\).)Tj
2.4774 0 Td
(Inclusion)Tj
3.9798 0 Td
(crite-)Tj
-35.4611 -1.2982 Td
(ria)Tj
1.2925 0 Td
(were:)Tj
2.3471 0 Td
(availability)Tj
4.5297 0 Td
(of)Tj
1.0148 0 Td
(clinico-pathological)Tj
8.1241 0 Td
(data,)Tj
2.143 0 Td
(the)Tj
1.4683 0 Td
(presence)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(enough)Tj
3.2201 0 Td
(tumor)Tj
2.7439 0 Td
(tissue)Tj
2.4548 0 Td
(and)Tj
-34.0665 -1.2983 Td
(good)Tj
2.228 0 Td
(RNA)Tj
2.262 0 Td
(quality)Tj
2.9537 0 Td
(to)Tj
1.0261 0 Td
(reliably)Tj
3.1691 0 Td
(determine)Tj
4.32 0 Td
(RT-qPCR)Tj
4.1556 0 Td
(levels)Tj
2.3754 0 Td
(\(see)Tj
1.7688 0 Td
(below\).)Tj
3.1521 0 Td
(After)Tj
2.2847 0 Td
(applying)Tj
3.6737 0 Td
(these)Tj
-33.3692 -1.3039 Td
(inclusion)Tj
3.9174 0 Td
(criteria,)Tj
3.2995 0 Td
(68)Tj
1.1735 0 Td
(primary)Tj
3.4526 0 Td
(tumors)Tj
3.1068 0 Td
(and)Tj
1.7291 0 Td
(60)Tj
1.1735 0 Td
(metastases)Tj
4.4334 0 Td
(remained,)Tj
4.2576 0 Td
(resulting)Tj
3.7304 0 Td
(in)Tj
1.0374 0 Td
(60)Tj
1.1679 0 Td
(paired)Tj
2.7609 0 Td
(pri-)Tj
-35.24 -1.2983 Td
(mary)Tj
2.296 0 Td
(BCs)Tj
1.8255 0 Td
(and)Tj
1.7291 0 Td
(metastases)Tj
4.439 0 Td
(from)Tj
2.2054 0 Td
(different)Tj
3.651 0 Td
(sites,)Tj
2.16 0 Td
(including)Tj
4.0422 0 Td
(brain)Tj
2.347 0 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.8051 0 Td
(12\),)Tj
1.7348 0 Td
(regional)Tj
3.4809 0 Td
(lymph)Tj
2.7893 0 Td
(nodes)Tj
-34.6108 -1.2983 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7993 0 Td
(20\),)Tj
1.7405 0 Td
(liver)Tj
1.9842 0 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7994 0 Td
(10\),)Tj
1.7405 0 Td
(ovary)Tj
2.4377 0 Td
(\(n)Tj
1.1112 0 Td
(=)Tj
0.7994 0 Td
(5\),)Tj
1.2585 0 Td
(lung)Tj
2.007 0 Td
(\(n)Tj
1.1111 0 Td
(=)Tj
0.7994 0 Td
(5\))Tj
1.0375 0 Td
(and)Tj
1.7291 0 Td
(other)Tj
2.3471 0 Td
(sites)Tj
1.9332 0 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7994 0 Td
(8,)Tj
0.924 0 Td
(consisting)Tj
4.269 0 Td
(of)Tj
1.0148 0 Td
(bone)Tj
-33.9588 -1.3039 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7993 0 Td
(2\),)Tj
1.2643 0 Td
(uterus)Tj
2.7269 0 Td
(\(n)Tj
1.1111 0 Td
(=)Tj
0.7994 0 Td
(1\),)Tj
1.2586 0 Td
(gastrointestinal)Tj
6.3496 0 Td
(tract)Tj
2.0466 0 Td
(\(n)Tj
1.1111 0 Td
(=)Tj
0.7994 0 Td
(2\))Tj
1.0375 0 Td
(and)Tj
1.7291 0 Td
(distant)Tj
2.9537 0 Td
(lymph)Tj
2.7836 0 Td
(node)Tj
2.228 0 Td
(metastases)Tj
-30.1037 -1.2982 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7993 0 Td
(3\)\).)Tj
1.6044 0 Td
(Clinico-pathological)Tj
8.3678 0 Td
(characteristics)Tj
5.9017 0 Td
(included)Tj
3.7134 0 Td
(age,)Tj
1.7688 0 Td
(primary)Tj
3.4526 0 Td
(tumor)Tj
2.7439 0 Td
(size,)Tj
1.9105 0 Td
(histological)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 409.4929 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(GRPR)Tj
3.0756 0 Td
(and)Tj
1.8567 0 Td
(SSTR2)Tj
3.4016 0 Td
(in)Tj
0.985 0 Td
(Breast)Tj
3.0615 0 Td
(Cancer)Tj
3.3874 0 Td
(Metastases)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0170)Tj
3.5434 0 Td
(536)Tj
2.6362 0 Td
(January)Tj
3.7134 0 Td
(20,)Tj
1.5874 0 Td
(2017)Tj
37.8003 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(12)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(This)Tj
1.7787 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8142 0 Td
(our)Tj
1.4741 0 Td
(adherence)Tj
4.0535 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3316 0 Td
(ONE)Tj
-15.8387 -1.3748 Td
(policies)Tj
3.0118 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
BT
10.5378 82.7156 Td
(materials.)Tj
ET
Q
endstream
endobj
39 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 42 0 R/Contents 43 0 R/TrimBox[0 0 612 792]>>
endobj
41 0 obj
<>
endobj
44 0 obj
<>
endobj
47 0 obj
<>stream
MinionPro-Regular 6 )
H? HL H\ ' - 3 > H N T Z ` j q t { +2=CIU[cnz~
"(.9CIOU[elov|&-8>DPV^iuy &+/49@DGLPU[]_ahjmru|
&-4;BIPW^elsz
")07>ELSZahov} %,3:AHOV]dkry#/;JTey ! ( / 6 = D K R Y ` g n u |
$
+
2
9
@
G
N
U
\
c
j
q
x
'.5<CJQX_fmt{ #*18?FMT[bkry
"
)
0
7
>
E
J
O
W
d
q
v
$+29@GNU\cjqx '.5<CJQX_fmt{ #*18?FMT[bipw~
&-4;BIPW^elsz !(/6=DOVcpuz-B\v$<Tdy*5@Tanz!2>O_fmt{ $-6?HQZclu~ )2;DMV^gpy $-6?HQZclu~ )2;DM\enwcommaaccentAbreveAmacronAogonekAEacuteCacuteCcaronCcircumflexCdotaccentDcaronDcroatEbreveEcaronEdotaccentEmacronEngEogonekGbreveGcircumflexGcommaaccentGdotaccentHbarHcircumflexIbreveIJImacronIogonekItildeJcircumflexKcommaaccentLacuteLcaronLcommaaccentLdotNacuteNcaronNcommaaccentObreveOhungarumlautOmacronOslashacuteRacuteRcaronRcommaaccentSacuteScedillaScircumflexScommaaccentTbarTcaronTcommaaccentUbreveUhungarumlautUmacronUogonekUringUtildeWacuteWcircumflexWdieresisWgraveYcircumflexYgraveZacuteZdotaccentIdotaccentabreveamacronaogonekaeacutecacuteccaronccircumflexcdotaccentdcarondcroatebreveecaronedotaccentemacronengeogonekgbrevegcircumflexgcommaaccentgdotaccenthbarhcircumflexibreveijimacroniogonekitildejcircumflexkcommaaccentlacutelcaronlcommaaccentldotnacutencaronncommaaccentobreveohungarumlautomacronoslashacuteracutercaronrcommaaccentsacutescedillascircumflexscommaaccenttbartcarontcommaaccentubreveuhungarumlautumacronuogonekuringutildewacutewcircumflexwdieresiswgraveycircumflexygravezacutezdotaccentkgreenlandiclongsnapostrophetonosdieresistonosAlphaBetaGammaDeltaEpsilonZetaEtaThetaIotaKappaLambdaMuNuXiOmicronPiRhoSigmaTauUpsilonPhiChiPsiOmegaAlphatonosEpsilontonosEtatonosIotatonosIotadieresisOmicrontonosUpsilontonosUpsilondieresisOmegatonosuni1FBBuni1F09uni1F0Duni1F0Buni1F0Funi1FB8uni1FBAuni1FBCuni1F89uni1F8Duni1F8Buni1F8Funi1F88uni1F8Cuni1F8Auni1F8Euni1F08uni1F0Cuni1F0Auni1F0Euni1FB9uni1FC9uni1F19uni1F1Duni1F1Buni1FC8uni1F18uni1F1Cuni1F1Auni1FCBuni1F29uni1F2Duni1F2Buni1F2Funi1FCAuni1FCCuni1F99uni1F9Duni1F9Buni1F9Funi1F98uni1F9Cuni1F9Auni1F9Euni1F28uni1F2Cuni1F2Auni1F2Euni1FDBuni1F39uni1F3Duni1F3Buni1F3Funi1FD8uni1FDAuni1F38uni1F3Cuni1F3Auni1F3Euni1FD9uni1FFBuni1F69uni1F6Duni1F6Buni1F6Funi1FFAuni1FFCuni1FA9uni1FADuni1FABuni1FAFuni1FA8uni1FACuni1FAAuni1FAEuni1F68uni1F6Cuni1F6Auni1F6Euni1FF9uni1F49uni1F4Duni1F4Buni1FF8uni1F48uni1F4Cuni1F4Auni1FECuni1FEBuni1F59uni1F5Duni1F5Buni1F5Funi1FE8uni1FEAuni1FE9alphabetagammadeltaepsilonzetaetathetaiotakappalambdanuxiomicronpirhosigmatauupsilonphichipsiomegaalphatonosepsilontonosetatonosiotatonosiotadieresisomicrontonosupsilontonosupsilondieresisomegatonosiotadieresistonosupsilondieresistonosuni03C2uni0374uni0375uni037Euni03D0uni03DAuni03DEuni03E0uni03F0uni1FBDuni1FBEuni1FC1uni1FCDuni1FCEuni1FCFuni1FDDuni1FDEuni1FDFuni1FEDuni1FEEuni1FFEuni1F00uni1F01uni1F02uni1F03uni1F04uni1F05uni1F06uni1F07uni1F10uni1F11uni1F12uni1F13uni1F14uni1F15uni1F20uni1F21uni1F22uni1F23uni1F24uni1F25uni1F26uni1F27uni1F30uni1F31uni1F32uni1F33uni1F34uni1F35uni1F36uni1F37uni1F40uni1F41uni1F42uni1F43uni1F44uni1F45uni1F50uni1F51uni1F52uni1F53uni1F54uni1F55uni1F56uni1F57uni1F60uni1F61uni1F62uni1F63uni1F64uni1F65uni1F66uni1F67uni1F70uni1F71uni1F72uni1F73uni1F74uni1F75uni1F76uni1F77uni1F78uni1F79uni1F7Auni1F7Buni1F7Cuni1F7Duni1F80uni1F81uni1F82uni1F83uni1F84uni1F85uni1F86uni1F87uni1F90uni1F91uni1F92uni1F93uni1F94uni1F95uni1F96uni1F97uni1FA0uni1FA1uni1FA2uni1FA3uni1FA4uni1FA5uni1FA6uni1FA7uni1FB0uni1FB1uni1FB2uni1FB3uni1FB6uni1FB7uni1FC2uni1FC3uni1FC4uni1FC6uni1FC7uni1FD0uni1FD1uni1FD2uni1FD3uni1FD6uni1FD7uni1FE0uni1FE1uni1FE2uni1FE3uni1FE4uni1FE5uni1FE6uni1FF2uni1FF3uni1FF4uni1FF6uni1FF7uni1FB4uni1FE7uniEFD5anoteleiauni03D1uni03D5uni03D6franclirapesetaEuroafii61289estimatedpartialdiffproductsummationuni2219radicalinfinityintegralapproxequalnotequallessequalgreaterequallozengeuni02C9uniEFEDuniEFEEuniEFF1uniEFF2uniEFF3uniEFF5uniEFF7AcuteCaronDieresisDieresisAcuteDieresisGraveGraveHungarumlautMacroncyrBrevecyrFlexdblGravecyrbrevecyrflexdblgravedieresisacutedieresisgraveuniF635uniF637uniF638uniF639uniF6DCuniF63AuniF63BuniF63CuniF63DuniF63EuniF63FuniF640uniF641uniF642uniF628uniF643uniF644uniF645uniF646uniF647uniF648uniF649uniF64AuniF64BuniF64CuniF64DuniF64EuniF64FuniF650uniF651uniF652uniF653uniF654uniF655uniF656uniF657uniF658uniF659uniF65AuniF65BuniF65CuniF65DuniF65EuniF65FuniF660uniF629uniF62AuniF62BuniF62CuniF62DuniF661uniF662uniF663uniF664uniF665uniF666uniF667uniF668uniF669uniF66AuniF66BuniF66CuniF62EuniF62FuniF630uniF631uniF632uniF66DuniF66EuniF66FuniF670uniF671uniF672uniF673uniF674uniF675uniF676uniF677uniF678uniF679uniF67AuniF67BuniF67CuniF67DuniF67EuniF67FuniF680uniF681uniF682uniF683uniF684uniF685uniF686uniF687uniF688uniF689uniF68AuniF68BuniF68CuniF68DuniF68EuniF68FuniF690uniF691uniF692uniF693uniF694uniF695uniF696uniF697uniF698uniF699uniF69AuniF69BuniF69CuniF69DuniF69EuniF69FuniF6A0uniF6A1uniF6A2uniF6A3uniF6A4uniF6A5uniF6A6uniF6A7uniF6A8uniF6A9uniF6AAuniF6ABuniF6ACuniF6ADuniF6AEuniF6AFuniF6B0uniF6B1uniF6B2uniF6B3uniF6B4uniF6B5uniF6B6uniF6B7uniF6B8uniF6B9uniF6BAuniF6BBuniF6BCuniF6BDuniF633c_hc_kc_tf_bf_f_bf_f_hf_f_kf_f_tf_hf_jf_f_jf_kf_ts_puniFB06T_hlongs_blongs_hlongs_ilongs_klongs_llongs_longsuniFB05longs_longs_ilongs_longs_la.ende.endm.endn.endr.endK.altR.altk.altcaron.altcommaaccent.altpeseta.altAlphaiotasub.altAlphaiotasubasper.altAlphaiotasubasperacute.altAlphaiotasubaspergrave.altAlphaiotasubaspertilde.altAlphaiotasublenis.altAlphaiotasublenisacute.altAlphaiotasublenisgrave.altAlphaiotasublenistilde.altEtaiotasub.altEtaiotasubasper.altEtaiotasubasperacute.altEtaiotasubaspergrave.altEtaiotasubaspertilde.altEtaiotasublenis.altEtaiotasublenisacute.altEtaiotasublenisgrave.altEtaiotasublenistilde.altOmegaiotasub.altOmegaiotasubasper.altOmegaiotasubasperacute.altOmegaiotasubaspergrave.altOmegaiotasubaspertilde.altOmegaiotasublenis.altOmegaiotasublenisacute.altOmegaiotasublenisgrave.altOmegaiotasublenistilde.altEuro.fittedcent.fittedcolonmonetary.fitteddollar.fittedflorin.fittedfranc.fittedlira.fittednumbersign.fittedsterling.fittedyen.fittedEuro.oldstylecolonmonetary.oldstyleestimated.oldstyleflorin.oldstylefranc.oldstylelira.oldstylenumbersign.oldstylesterling.oldstyleyen.oldstylefranc.taboldstylelira.taboldstyleorn.001orn.002orn.003orn.004orn.005orn.006orn.007orn.008orn.009orn.010orn.011orn.012orn.013orn.014orn.015orn.016orn.017orn.018orn.019orn.020orn.021orn.022orn.023afii10023afii10031afii10022afii10049T_h.caronafii10070afii10196afii10026afii10021afii10846afii10193afii10107afii10024afii10195afii10041afii10037afii10109afii10053afii10045afii10108afii10040afii10104afii10036afii10078afii10074afii10060afii10046afii10052afii10087afii10050afii10145afii10057afii10059afii10146afii10088afii10101afii10054afii10058Rholenisafii10025afii10099afii10068afii10035afii10048afii10089afii10105afii10085afii10020afii10077afii10106afii10019afii10076afii10110afii10100afii10090afii10028afii10095afii10147afii10066afii10098afii10082afii10061afii10103afii10102afii10083afii10027afii10072afii10039afii61352afii10069afii10094afii10038afii10034afii10148afii10032afii10194afii10033afii10075afii10017afii10081afii10056afii10084afii10044afii10030afii10051afii10047afii10018afii10080afii10042afii10071afii10029afii10062afii10065afii10097T_h.commaaccentafii10096afii10079afii10091afii10093afii10064afii10043afii10092uni2215uni021Bafii10073afii10067uni00A0uni021Aafii10086afii10055uni0394uni03BCuni03A9uni00ADCopyright 2000 Adobe Systems Incorporated. All Rights Reserved. U.S. Patent Des. 337,604.Minion is either a registered trademark or a trademark of Adobe Systems Incorporated in the United States and/or other countries.Minion Pro RegularMinion Pro% i WZ5:`v22> % I
/
2
I
o
#3p~U
D
e
!o#]emE %<Jeov~EMfjtFp|,S-AZ0=DK +^&7NQy(/S_dl 5Rk$=Valsz"'-@T_gos{ ) . > N ^ d n v ~ !!!!'!3!?!H!Q!Z!]!c!i!n!s!x!!!!!!!!!!!!!"""#"'"3"?"K"W"c"k"s"{""""""""""""""c&oEr^7 JB@H *W2c~sp&m!1= 4:$kYyywRvzwrZnon?˘iNUddLoLݪ
~}}vywS6vO(Zp^TrǕ؍8x`?NYwUVYWE}zyMhummR~Kfowx}|txcBzuyBpOwTxql[LPҩy}~Bxxhzqlc#T0@9
5/j,X^M8Uruuoquvqiff{bE<H8XUo^bb_rMG'Н=[W}yQSSۚ$P|TzTyT'
ajqyzx||rrpwttozpj`lWHrʥaiqyo
|rqpxt@tpyqjalVHr]yt/m'mDx]pIsn8AgmxpQAz4wv~s}~vstzf|oęgfeoszvwzxu$wny|YgJO-ʆea]>9+ZhchAB_\?#^|m[5v-<<[FL LHHq˂~XxAo4uFabfqaf%f+rrs}ǔcqW "* ڟŇՊvx|po~}wUJN<0o-כtzr[ {"!coч~^o]/6'orsBp0ZlZqRoGt{_Fpq|iiMkTratap`DabuvCICpAϦ{~{lpˇBDDpӐ qoكtYoNU)gI_Z`yӔodžF/INlw71oC
ŸԱȗГnoՆ3$811xrdcQD:0] ;hJjp~djmplXhZfYxnmmyf^#MR:AgszvT]jjZ?_ynZQ{sNHyZdƨ]O틯֯}ޣDyZ{kvumofFMk_VYЄ#ms^@L A_!Z Z|蒯}~rqyg|usqrwgmazԬqbfZBoل5|%69o<3oZMZJuׇ3c T{ddmvrjY_VpŇkrkGpφ}8Fgsmy]pWSy/OBR7WXjfeolw}v84o~}xUGP~72pC
~㿊IK
NϪb98IPq
`y[~XsłI\FL
ދ.R۲vhl_@oۅ8(85oq͗ƫ>(3XOG7]_\i^%"Ba:Jy.}eu}|wzq]is|~ґϐuCDDEp
ؑ~P|xhcMp^},
qkuGuzwv~s}~ust}e{nęgfR5BcH
蠓`
i
`c
v
y
蠚}xsnyvrpyh&T~Y|S|Q4xrqxvrpyhrqVVrm